Recent House of Representatives committee hearings have focused on a variety of health care policy issues, including the following:
- Energy and Commerce Committee hearings on: the growth and oversight of the 340B drug discount program; drug and device company communications, including clinical/economic data; state efforts to address the opioid crisis; and extension of safety net